• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Pentasa Enema
    / Ferring Pharmaceuticals


    Active Ingredient
    Mesalazine 1 g/ 100 ml

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Enema

    7 X 1 g / 100 ml

    full basket chart 7900 16916, 16895, 16544

    Dosage

    1 enema at bedtime. A visit to the toilet is recommended before administration of enemas and suppositories. Instructions for use appear in the Patient Leaflet.
    Shake the enema container well before use. The enema is protected by an aluminium foil bag and should be used immediately after opening.


    Indications

    Crohn’s disease, ulcerating colitis.


    Contra-Indications

    Hypersensitivity to mesalazine, any other component of the product or salicylates. Severe liver and/or renal impairment.


    Special Precautions

    Patients allergic to sulphasalazine (risk of allergy to salicylates).


    Side Effects

    N/A


    Drug interactions

    Aspirin, diphenhydramine, probenicid, isoniazide, rifamipicin.


    Manufacturer
    Ferring Pharmaceuticals
    CLOSE